Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 9, 2008, Pages 861-868

  Main, Penelope ^a   Robinson, Maxine ^a  

^a Department of Health and Ageing ^*  (Australia)

Author keywords

Drug utilisation; Hormone replacement therapy; Media reports; Women's health initiative

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE; PROGESTERONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; COMBINATION CHEMOTHERAPY; COST BENEFIT ANALYSIS; DRUG COST; DRUG UTILIZATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MONOTHERAPY; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; RETROSPECTIVE STUDY; WOMEN'S HEALTH;

AGED; AUSTRALIA; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MASS MEDIA; MIDDLE AGED; PUBLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WOMEN'S HEALTH;

EID: 52949104731     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1605     Document Type: Article

References (12)

1. Writing Group for the WHI Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321-332.
2. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291(14): 1701-1712.
3. Shumaker S, Legault C, Kuller L, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory study: a randomized controlled trial. JAMA 2003; 289(20): 2651-2662.
4. Lacey JV, Jr, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002; 288(3): 334-341.
5. Gittins R. Medicos are using selective surgery on their statistics. The Sydney Morning Herald. 7 August 2002; 13.
6. Travers C, O'Neill SM, Khoo SK, King R. Hormones down under: hormone therapy use after the Women's Health Initiative. Aust N Z J Obstet Gynaecol 2006; 46(4): 330-335.
7. MacLaren AH, Taylor AW, Wildon DH. Hormone therapy use after the Women's Health Initiative. Climacteric 2004; 7: 138-142.
8. Buick EL, Crook D, Horne R. Women's perceptions of hormone replacement therapy: risks and benefit (1980-2002): a literature review. Climactic 2005; 8: 24-35.
9. Hersh AL, Stefanick ML, Stafford RS. National use of post-menopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291(1): 47-53.
10. Ettinger B, Grady D, Tosteson ANA, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003; 102(6): 1225-1232.
11. Barber CA, Margolils K, Luepker RV, Arnett DK. The impact of the Women's Health Initiative on discontinuation of post-menopausal hormone therapy: the Minnesota Heart Survey (2000-2000). J Women's Health 2004; 13(9): 975-985.
12. Hillman JJ, Zuckerman IH, Lee E. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program. J Women's Health 2004; 13(9): 986-992.